Home » Newsletters » BioWorld Science

BioWorld Science

May 26, 2016

View Archived Issues

New drug for GI radiation injury

ABLS II completes drug candidate feasibility program

CD31 expression on CD4 T cells correlated with respiratory disease in premature infants

P2Y6 receptor identified as a therapeutic target for asthma

Monoclonal antibody targets gastric inhibitory polypeptide to treat obesity

Acad10 gene knockout mice are a potential model of diabetes

Lundbeck patents BACE1 inhibitors

Bristol-Myers Squibb divulges IDO inhibitors to treat cancer

Lysosomal Therapeutics announces glucosylceramidase activators

Amorsa Therapeutics presents NMDA receptor antagonists

Eli Lilly introduces drug conjugates for bone disorders

Seed funding for Global Antibiotic Research and Development partnership

FDA will not meet PDUFA date for Sarepta's eteplirsen NDA

Eisai launches Fycompa tablets in Japan

Tetragenetics begins partnership with Theranyx

FDA grants fast track status to Novavax's RSV F vaccine

Alkermes begins phase I trial of ALKS-4230

Successful phase II results for solithromycin in community-acquired bacterial pneumonia

Kamada's alpha1-antitrypsin is available in Europe via myTomorrows early access platform

FDA advisory committee recommends approval of insulin glargine/lixisenatide

Juno Therapeutics signs intent to collaborate with Seattle Children's

SEATTLE study of emixustat in geographic atrophy fails to meet primary endpoint

BioXcel and Alnylam enter strategic collaboration to discover novel RNAi therapeutics

Michael J. Fox Foundation for Parkinson's Research announces new funding and partnership

FDA grants orphan drug designation to Viamet's VT-1598

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...